BioScience Trends

886 papers and 14.9k indexed citations i.

About

The 886 papers published in BioScience Trends in the last decades have received a total of 14.9k indexed citations. Papers published in BioScience Trends usually cover Molecular Biology (229 papers), Epidemiology (159 papers) and Surgery (126 papers) specifically the topics of Hepatocellular Carcinoma Treatment and Prognosis (58 papers), Liver Disease Diagnosis and Treatment (39 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (35 papers). The most active scholars publishing in BioScience Trends are Hongzhou Lu, Jianjun Gao, Xu Yang, Peipei Song, Fanghua Qi, Wei Tang, Ling Wang, Tianqiang Song, Yunfei Lu and Xiaorong Chen.

In The Last Decade

Fields of papers published in BioScience Trends

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in BioScience Trends. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in BioScience Trends

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in BioScience Trends. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in BioScience Trends with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025